相关实验视频

Updated: May 31, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

来自基奥斯马斯蒂哈树脂的triterpenoids与MASLD-A分子对接调查对抗

Nataša Milošević¹, Maja Milanović¹, Milica Medić Stojanoska^2,3

¹Department of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.

Current issues in molecular biology

|January 24, 2025

概括

与代谢功能障碍相关的脂肪性肝病 (MASLD),以前称为NAFLD,可能可以用基奥斯 mastiha树脂的化合物来治疗. 分子对接表明这些化合物有效地准关键的MASLD相关受体.

科学领域:

肝病学肝病学是一种肝病学.
药理学药理学是指药理学的学科.
生物化学生物化学

背景情况:

非酒精性脂肪肝 (NAFLD) 是一种普遍的慢性肝病,缺乏特定药物治疗.
为了强调其代谢基础,NAFLD被重新定义为与代谢功能障碍相关的脂肪性肝病 (MASLD).
奇奥斯马斯蒂哈树脂显示了对MASLD的潜在治疗益处.

研究的目的:

调查基奥斯马斯蒂哈树脂中的16种化合物作为MASLD治疗剂的潜力.
通过分子对接来评估这些化合物与参与MASLD病变发生的关键受体的结合亲和力.

主要方法:

利用分子对接模拟来评估连接体-受体相互作用.
选了来自奇奥斯 mastiha树脂的16种化合物.
目标受体包括GR,LXRα/β,PPARα/γ,MC4R,AMPK和VEGFR2,所有这些都与MASLD有关.

主要成果:

化合物对LXR,GR,MC4R和PPARγ受体表现出中度至高的结合亲和力.
对PPARα,AMPK和VEGFR2的结合亲和力不那么显著.
该研究确定了具有潜在MASLD调节特性的特定基奥斯 mastiha化合物.

结论:

奇奥斯马斯蒂哈树脂含有具有对MASLD有前途的治疗潜力的化合物.
多种活性化合物的联合作用可能为管理复杂的MASLD代谢途径提供了优越的策略.
需要进一步研究基奥斯马斯蒂哈对MASLD的治疗应用.

关键词:

这是一种抗肥胖的药物.生物活动是生物活动.分子对接的分子对接.分子点是分子点.自然化合物自然化合物无酒精性肝病是一种非酒精性肝病.

更多相关视频

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

相关概念视频

Molecules with Multiple Chiral Centers

Molecules with Multiple Chiral Centers

Molecules that possess multiple chiral centers can afford a large number of stereoisomers. For instance, while some molecules like 2-butanol have one chiral center, defined as a tetrahedral carbon atom with four different substituents attached, several molecules like butane-2,3-diol have multiple chiral centers. A simple formula to predict the number of stereoisomers possible for a molecule with n chiral centers is 2n. However, there can be a lower number where some of the stereoisomers are...